IPO Databook: INVO Fertility (IVF US) - Jul 2026

115 Views26 Jul 2026 10:01

SUMMARY

INVO Fertility, Inc. is a healthcare services and technology company focused on the fertility marketplace, expanding access to assisted reproductive technology (ART) care.
Proprietary INVOcell® device enables in vivo fertilization and early embryo development, demonstrating equivalent pregnancy success and live birth rates as IVF.
Auditors' reports for December 31, 2025 and 2024 contain an explanatory paragraph relating to the ability to continue as a going concern.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Discussions

(Paid Plans Only)

Price Chart(Sign Up to Access)

Insight Stream